Factors affecting changes in immunohistochemistry phenotype of breast cancer

Background: Modern clinical trials indicate that during system treatment change of breast cancer phenotype is observed quite often. Aim: The aim of work was research of frequency of changes and factors that influenced on the changes of immunohistochemistry (IHC) status of tumor in the process of treatment and initiation. Material and Methods: Clinical data of 65 patients with breast cancer was analyzed